The IPKat

Thinking beyond the sequence: CAR-T cell therapy litigation at the UPC (2seventy bio v Johnson & Johnson, UPC_CFI_029/2026)

The validity and value of cell therapy safety protocol inventions (T 1555/23)

The reproducibility challenge for advanced therapies (T 0827/23)

Why patents matter: Understanding the importance of IP in the pharma industry

Are AI-discovered drug patents blocking innovation? A response to the Science article

IP implications of the FDA guidance for use of AI in drug development